Global Interventional oncology Market
                     Global Interventional oncology Market was valued US$ XX Mn. in 2019 and is 
expected to reach US$ XX Mn. by 2027, at a CAGR of 7.9% during a forecast 
period.
 
Product Definition
Interventional oncology is a subspecialty area of interventional radiology 
that offers with the diagnosis and treatment of most cancers and most cancers-
related problems using focused minimally invasive tactics achieved underneath 
image guidance.
(The report study has analyzed revenue impact of COVID -19 pandemic on the 
sales revenue of market leaders, market followers and market disrupters in the
report and same is reflected in our analysis.)
Market Dynamics
Interventional oncology has evolved into a separate pillar of cutting-edge 
oncology and it employs X-ray, ultrasound, computed tomography (CT) or 
magnetic resonance imaging (MRI) to help guide miniaturized contraptions to 
permit focused and precise treatment of solid tumors positioned in various 
organs of the human body. Interventional oncology procedures are usually 
divided among diagnostic strategies that help obtain tissue diagnosis of 
suspicious neoplasms and therapeutic ones that goal to cure therapy or 
palliate the tumor. Both ablation and embolization techniques are minimally 
invasive treatments.
The worldwide interventional oncology market is ordinarily compelled with the 
aid of excessive occurrence and upsurge in the prevalence rates of most 
cancers worldwide. Cancer is the second one main cause of death globally, 
accounting for an expected 9.6 million deaths, or one in six deaths, in 2018. 
According to GLOBOCAN, in 2018 here will be an estimated 18.1 million new 
cancer cases and 9.6 million cancer deaths in 2018. In both sexes combined, 
lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) 
and the leading cause of cancer death (18.4% of the total cancer deaths), 
closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and 
colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach 
cancer (8.2%), and liver cancer (8.2%) for mortality. Benefits of minimally 
invasive surgical methods, technological improvements in interventional 
oncology, expanded authorities funding for oncology procedures etc. are 
projected to boost the growth of the interventional oncology market throughout
the forecast duration.
Every month within the United States, more than 1.6 million people are 
diagnosed with most cancers, and approximately 600,000 die from it. The value 
of most cancers care maintains to upward thrust and is predicted to reach 
almost US$174 billion by way of 2020.
Global Interventional oncology Market Segment analysis
Based at the Product, the tumor embolization procedures segment is projected 
to grow at a CAGR of XX% for the duration of the forecast duration. Tumor 
embolization procedures commanded the largest share of the worldwide 
interventional oncology market in 2019 mainly because of their wide 
utilization with high sensitivity, specificity, and accuracy in the direction 
of the detection and characterization of tumors. Furthermore, the improvements
in embolization techniques together with studies applications for the 
improvement of yttrium 90 isotopes efficiency have brought about a growth in 
demand for embolization procedures worldwide.
Global Interventional oncology Market Regional analysis
North America is anticipated to dominate the worldwide interventional oncology
market throughout the estimate period. For the main share of the global 
interventional oncology market owing to a large populace base troubled with 
chronic cancer. Additionally substantial acceptance of minimally invasive 
surgical procedures for the influential management of cancer, well-set-up 
health care infrastructure, and early acceptance of technically progressive 
interventional oncology products etc. are factors that can be probable to 
impel the growth of the interventional oncology market during the forecast 
period. Besides, the U.S. most cancers care expenditure was $50 billion in 
2017. In forthcoming, costs are possible to upsurge as the populace ages and 
most cancers incidences increases. Thus, factors consisting of growing cancer 
prevalence, growing most cancers-related healthcare expenditure, and demand 
for advanced cancer care alternatives are propelling the adoption of 
interventional oncology.
The interventional oncology market in the Asia Pacific is expected to increase
at a high CAGR during the estimate duration due to high incidence of cancer in
the highly populous countries of India and China, rapidly converting health 
care systems, numerous authorities’ initiatives to improve usual health care, 
and elevated in keeping with capita health care expenditure.
The objective of the report is to present a comprehensive analysis of the 
Global Interventional oncology Market including all the stakeholders of the 
industry. The past and current status of the industry with forecasted market 
size and trends are presented in the report with the analysis of complicated 
data in simple language. The report covers all the aspects of the industry 
with a dedicated study of key players that includes market leaders, followers 
and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of 
micro-economic factors of the market has been presented in the report. 
External as well as internal factors that are supposed to affect the business 
positively or negatively have been analysed, which will give a clear 
futuristic view of the industry to the decision-makers.
The report also helps in understanding Global Interventional oncology Market 
dynamics, structure by analysing the market segments and projects the Global 
Interventional oncology Market size. Clear representation of competitive 
analysis of key players by Application, price, financial position, Product 
portfolio, growth strategies, and regional presence in the Global 
Interventional oncology Market make the report investor’s guide.
https://www.maximizemarketresearch.com/market-report/global-interventional-
oncology-market/57766/
Scope of the Global Interventional oncology
Market
Global Interventional oncology Market, By Procedure
• Ablation Devices
o Microwave ablation
o Radiofrequency ablation
o Cryoablation
o Others
• Embolization Devices
• Micro catheters
• Guide wires
• Others
Global Interventional oncology Market, By Product
• Tumor Embolization
o Radioembolic agents
o Non-radioactive embolic agents
o Tumor Ablation
Global Interventional oncology Market, By Cancer Type
• Lung cancer
• Breast Cancer
• Liver Cancer
• Kidney Cancer
• Prostate Cancer
• Others
Global Interventional oncology Market, By Regions
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa (MEA)
Key Players operating the Global Interventional oncology 
Market
• Boston Scientific
• BTG
• Medtronic
• Merit Medical
• Terumo
• Accuray
• Alpinion Medical Systems
• Angiodynamics
• Atricure
• Baylis Medical
• Bovie Medical
• Brainlab
• Bsd Medical
• C. R. Bard
• C2 Therapeutics
• Cardiofocus
• Cook Medical
• Eckert And Ziegler Bebig
• Edap Tms
• Elekta
• Galil Medical
• Healthtronics